Takahashi H, Kirsch J R, Hashimoto K, London E D, Koehler R C, Traystman R J
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, Md, USA.
Stroke. 1995 Sep;26(9):1676-82. doi: 10.1161/01.str.26.9.1676.
We tested the hypothesis that administration of 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP), a potent sigma-receptor ligand, during transient focal ischemia would affect early postischemic brain injury.
Halothane-anesthetized cats underwent left middle cerebral artery occlusion for 90 minutes followed by 4 hours of reperfusion. Control cats received saline (n = 10). Experimental cats (2 groups, n = 10 per group) were treated with PPBP at a rate of 0.1 mumol/kg per hour (PPBP-0.1) or administered 1 mumol/kg per hour (PPBP-1) intravenously from 75 minutes after initiation of ischemia and continuing during the 4 hours of reperfusion.
As measured by the microsphere method, blood flow to the ipsilateral caudate nucleus was decreased similarly in all groups during ischemia. Blood flow to the ipsilateral inferior temporal cortex was decreased during ischemia in all groups but was higher in cats subsequently treated with PPBP at the highest dose, even before drug administration. There was no difference in blood flow to the ipsilateral caudate nucleus or inferior temporal cortex (area of greatest cortical injury) during reperfusion. Triphenyltetrazolium-determined injury volume of the ipsilateral cerebral hemisphere (control, 29 +/- 5%; PPBP-0.1, 17 +/- 3%; PPBP-1, 6 +/- 1% of ipsilateral hemisphere; mean +/- SEM) and caudate nucleus (control, 49 +/- 5%; PPBP-0.1, 39 +/- 6%; PPBP-1, 25 +/- 5% of ipsilateral caudate nucleus) was less in cats treated with 1 mumol/kg per hour of PPBP compared with cats treated with saline. Cats treated with 0.1 mumol/kg per hour had a 45% smaller hemispheric injury volume than the control group without differences in intraischemic blood flow. Recovery of somatosensory evoked potential amplitude was greater in cats treated with PPBP-1 compared with control (control, 18 +/- 11%; PPBP-0.1, 30 +/- 14%; PPBP-1, 54 +/- 14% of baseline).
These data indicate that sigma-receptors may play an important role in the mechanism of acute injury in both the cortex and the caudate nucleus after 90 minutes of transient focal ischemia in the cat. Because PPBP afforded protection when administered at the end of ischemia and during reperfusion, sigma-receptors may contribute to the progression of injury in ischemic border regions.
我们检验了如下假设,即在短暂性局灶性脑缺血期间给予强效σ受体配体4-苯基-1-(4-苯基丁基)哌啶(PPBP)会影响缺血后早期脑损伤。
用氟烷麻醉的猫接受左侧大脑中动脉闭塞90分钟,随后再灌注4小时。对照组猫接受生理盐水(n = 10)。实验猫(2组,每组n = 10)在缺血开始后75分钟开始以0.1 μmol/kg每小时的速率静脉给予PPBP(PPBP - 0.1)或1 μmol/kg每小时(PPBP - 1),并在4小时的再灌注期间持续给药。
通过微球法测量,在缺血期间所有组同侧尾状核的血流量均以相似的程度减少。在缺血期间所有组同侧颞下回皮质的血流量均减少,但在随后接受最高剂量PPBP治疗的猫中,即使在给药前血流量也更高。在再灌注期间,同侧尾状核或颞下回皮质(皮质损伤最严重的区域)的血流量没有差异。用三苯基四氮唑测定的同侧脑半球损伤体积(对照组,29±5%;PPBP - 0.1组,17±3%;PPBP - 1组,占同侧半球的6±1%;平均值±标准误)和尾状核损伤体积(对照组,49±5%;PPBP - 0.1组,39±6%;PPBP - 1组,占同侧尾状核的25±5%),与接受生理盐水治疗的猫相比,每小时给予1 μmol/kg PPBP治疗的猫更小。每小时给予0.1 μmol/kg治疗的猫半球损伤体积比对照组小45%,而缺血期间血流量无差异。与对照组相比,接受PPBP - 1治疗的猫体感诱发电位幅度的恢复更大(对照组,18±11%;PPBP - 0.1组,30±14%;PPBP - 1组,为基线的54±14%)。
这些数据表明,σ受体可能在猫短暂性局灶性脑缺血90分钟后皮质和尾状核的急性损伤机制中起重要作用。由于PPBP在缺血末期和再灌注期间给药时提供了保护,σ受体可能在缺血边缘区域的损伤进展中起作用。